Alnylam Pharmaceuticals (ALNY) PT Raised to $206 at Leerink Partners
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $228.65 --0%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Join SI Premium – FREE
Leerink Partners analyst Mani Foroohar raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $206.00 (from $200.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- ADC Therapeutics (ADCT) PT Lowered to $5 at Guggenheim
- Acadia Pharmaceuticals (ACAD) PT Raised to $49 at UBS
- Burlington Stores (BURL) PT Raised to $440 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
